Unexplained fever in neonates may be associated with hepatitis B vaccine
- PMID: 10525025
- PMCID: PMC1721007
- DOI: 10.1136/fn.81.3.f206
Unexplained fever in neonates may be associated with hepatitis B vaccine
Abstract
Aim: To investigate whether hepatitis B vaccination has increased the number of cases of unexplained neonatal fever.
Method: The files of all infants born from 1 January 1991 to 31 December 1992, in whom a diagnosis of "injected antibiotic" or "disease of temperature regulation" was recorded, were reviewed. Those who had unexplained fever of 38 degrees C or higher during the first three days of life were divided into two groups: infants who did not receive the hepatitis B vaccine (1991) and infants who did (1992).
Results: In 1992 the incidence of unexplained fever in hepatitis B vaccinated neonates was significantly higher than in the 1991 group of pre-vaccination neonates (35 out of 5819 (0.6%) vs 14 out of 5010 neonates (0.28%) respectively, p=0.013).
Conclusions: The increase in the number of cases of unexplained neonatal fever seems to be associated with the introduction of routine hepatitis B vaccination on the first day of life. The possibility that an excess number of neonates will undergo unnecessary procedures and treatment to diagnose unexplained fever justifies planning a controlled study to determine whether these preliminary findings point to a significant problem.
Similar articles
-
Safety of neonatal hepatitis B vaccine administration.Pediatr Infect Dis J. 2001 Nov;20(11):1049-54. doi: 10.1097/00006454-200111000-00009. Pediatr Infect Dis J. 2001. PMID: 11734710
-
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977. Pediatrics. 2008. PMID: 19047220
-
Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.Pediatr Infect Dis J. 2007 Apr;26(4):329-33. doi: 10.1097/01.inf.0000258616.12752.51. Pediatr Infect Dis J. 2007. PMID: 17414397
-
Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.Vaccine. 2015 Aug 7;33(33):4093-9. doi: 10.1016/j.vaccine.2015.06.081. Epub 2015 Jul 3. Vaccine. 2015. PMID: 26144895 Clinical Trial.
-
Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.Vaccine. 2013 May 17;31(21):2506-16. doi: 10.1016/j.vaccine.2012.12.012. Epub 2012 Dec 17. Vaccine. 2013. PMID: 23257713 Review.
Cited by
-
Fever in healthy asymptomatic newborns during the first days of life.Arch Dis Child Fetal Neonatal Ed. 2003 Jul;88(4):F312-4. doi: 10.1136/fn.88.4.f312. Arch Dis Child Fetal Neonatal Ed. 2003. PMID: 12819164 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources